Cell Culture Media for Vaccine Market - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

Cell Culture Media for Vaccine Market - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

Cell culture media consists an appropriate source of energy and compounds, which supports growth of cells and regulate the cell cycle. A typical culture medium is composed of vitamins, inorganic salts, complement of amino acids, glucose, and serum which acts as source of growth factors, hormones, and attachment factors. Furthermore, the medium also helps to maintain pH and osmolality.
Market Dynamics
Increasing prevalence of infectious diseases is a major factor driving the global cell culture media for vaccine market growth. According to the Centers for Disease Control and Prevention (CDC), in August 2021, around 104 laboratory-confirmed influenza-associated pediatric deaths were reported, where 66 cases were associated with influenza A viruses and 38 cases were associated with influenza B viruses in the U.S. Moreover, the government initiatives for increasing awareness among the populace regarding prevention of diseases facilitated by vaccines is expected to boost the market growth. For instance, according to the Centers for Disease Control and Prevention (CDC), in 2015, flu vaccinations prevented around 1.9 million flu illnesses, 966,000 flu-associated medical visits, and around 67,000 flu-associated hospitalizations, representing 6.5% lowering of disease burden in the U.S.
However, high risk of contamination may hinder the market growth. According to the article published in ResearchGate, 2014, fetal bovine serum (FBS) is known to contain factors such as endotoxins, mycoplasma, viral contaminants, and prions that can lead to bovine spongiform encephalopathy (BSE).
Key features of the study:
This report provides in-depth analysis of the global cell culture media for vaccine market and provides market size (US$ million) and Compound Annual Growth Rate (CAGR %) for the forecast period (2022-2028), considering 2021 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights into market drivers, restraints, opportunities, impact analysis, Porter’s analysis, PEST analysis, regulatory scenario, key developments, raw material analysis, and supply chain analysis
It profiles key players in the global cell culture media for vaccine market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
Key companies covered as a part of this study include HiMedia Laboratories, Thermo Fisher Scientific Inc., Merck KGaA, General Electric Company, Sartorius AG, Proliant, Inc., Bovogen Biologicals Pty. Ltd., Rocky Mountain Biologicals, Valley Biomedical, Moregate BioTech, Atlanta Biologicals, Creative-Biolabs, Life Technologies (India) Pvt Ltd., Axil Scientific Pte Ltd., Indian Immunologicals Limited, Serum Institute of India Pvt. Ltd., Sisco Research Laboratories Pvt. Ltd., and Valneva SE
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
The global cell culture media for vaccine market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global cell culture media for vaccine market
Detailed Segmentation:
Global Cell Culture Media for Vaccine Market, By Media Type:
Bovine Derived
Fetal bovine serum (FBS)
Newborn Calf Serum (NBCS)
Adult Bovine Serum (ABS)
Bovine Serum Albumin (BSA)
Bovine Calf Serum (BCS)
Porcine Derived
Animal free/Serum Free Cell Culture
Global Cell Culture Media for Vaccine Market, By Application:
Human Vaccines
Animal Vaccines
Global Cell Culture Media for Vaccine Market, By Geography:
North America
By Media Type:
Bovine Derived
Fetal bovine serum (FBS)
Newborn Calf Serum (NBCS)
Adult Bovine Serum (ABS)
Bovine Serum Albumin (BSA)
Bovine Calf Serum (BCS)
Porcine Derived
Animal free/Serum Free Cell Culture
By Application:
Human Vaccines
Animal Vaccines
By Country:
U.S.
Canada
Latin America
By Media Type:
Bovine Derived
Fetal bovine serum (FBS)
Newborn Calf Serum (NBCS)
Adult Bovine Serum (ABS)
Bovine Serum Albumin (BSA)
Bovine Calf Serum (BCS)
Porcine Derived
Animal free/Serum Free Cell Culture
By Application:
Human Vaccines
Animal Vaccines
By Country:
Brazil
Mexico
Argentina
Rest of Latin America
Europe
By Media Type:
Bovine Derived
Fetal bovine serum (FBS)
Newborn Calf Serum (NBCS)
Adult Bovine Serum (ABS)
Bovine Serum Albumin (BSA)
Bovine Calf Serum (BCS)
Porcine Derived
Animal free/Serum Free Cell Culture
By Application:
Human Vaccines
Animal Vaccines
By Country:
Germany
U.K.
France
Italy
Spain
Russia
Rest of Europe
Asia Pacific
By Media Type:
Bovine Derived
Fetal bovine serum (FBS)
Newborn Calf Serum (NBCS)
Adult Bovine Serum (ABS)
Bovine Serum Albumin (BSA)
Bovine Calf Serum (BCS)
Porcine Derived
Animal free/Serum Free Cell Culture
By Application:
Human Vaccines
Animal Vaccines
By Country:
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Middle East
By Media Type:
Bovine Derived
Fetal bovine serum (FBS)
Newborn Calf Serum (NBCS)
Adult Bovine Serum (ABS)
Bovine Serum Albumin (BSA)
Bovine Calf Serum (BCS)
Porcine Derived
Animal free/Serum Free Cell Culture
By Application:
Human Vaccines
Animal Vaccines
By Country:
GCC
Israel
Rest of Middle East
Africa
By Media Type:
Bovine Derived
Fetal bovine serum (FBS)
Newborn Calf Serum (NBCS)
Adult Bovine Serum (ABS)
Bovine Serum Albumin (BSA)
Bovine Calf Serum (BCS)
Porcine Derived
Animal free/Serum Free Cell Culture
By Application:
Human Vaccines
Animal Vaccines
By Country:
South Africa
Central Africa
North Africa
Company Profiles
HiMedia Laboratories *
Company Overview
Product Portfolio
Financial Performance
Key Highlights
Market Strategies
Thermo Fisher Scientific, Inc.
Merck KGaA
General Electric Company
Sartorius AG
Proliant, Inc.
Bovogen Biologicals Pty. Ltd.
Rocky Mountain Biologicals
Valley Biomedical
Moregate BioTech
Atlanta Biologicals
Creative-Biolabs
Life Technologies (India) Pvt Ltd.
Axil Scientific Pte Ltd.
Indian Immunologicals Limited
Serum Institute of India Pvt. Ltd.
Sisco Research Laboratories Pvt. Ltd.
Valneva SE
“*” marked represents similar segmentation in other categories in the respective section.